On June 2, 2011, Chad Landmon, Chair of the FDA Practice Group at Axinn, Veltrop & Harkrider LLP, delivered an FDAnews Webinar entitled, “How to Align the FDA Approval Process with Paragraph IV Strategy: Tips, Best Practices and Case Studies to Optimize FDA Results.” The presentation discussed strategies toproactively approach Paragraph IV litigation in order to better serve a company's overall business goals. Details on the webinar can be found here:  CTDOCS-42686-v1-FDAnews_PIV_Disputes_Webinar.PPT